| Title | Guidance: Failure to Respond to an Abbreviated New Drug Application Complete Response Letter within the Regulatory Timeframe |
| ToC Doc | Failure to Respond to an Abbreviated New Drug Application Complete Response Letter within the Regulatory Timeframe |
| Docket Number | 2022-15825 |
| Type | Notice |
| Subject | Guidance: Failure to Respond to an Abbreviated New Drug Application Complete Response Letter within the Regulatory Timeframe |
| Publication Date | 2022-07-25 |
| Last Updated Date | 2022-07-22 08:15:07 -0400 |
| Last Public Inspection | 2022-07-22 |
| Filed At | 2022-07-22T08:45:00.000-04:00 |
| 2022-15825_PI.pdf (118799 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 5 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...